SeaCrest Wealth Management’s Globus Medical GMED Stock Holding History

SeaCrest Wealth Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-549	Closed	-$31K	–	966
2022 Q2	$31K	Buy	+549	New	+$36.1K	﹤0.01%	1314
2019 Q2	–	Sell	-1,871	Closed	-$92K	–	1034
2019 Q1	$92K	Buy	1,871 +342	+22%	+$15.5K	0.02%	718
2018 Q4	$66K	Sell	1,529 -476	-24%	-$23.8K	0.01%	806
2018 Q3	$114K	Buy	2,005 +37	+2%	+$1.95K	0.02%	695
2018 Q2	$99K	Buy	1,968 +466	+31%	+$24.3K	0.02%	726
2018 Q1	$75K	Sell	1,502 -49	-3%	-$2.3K	0.01%	796
2017 Q4	$64K	Buy	+1,551	New	+$54.3K	0.01%	865

Other funds holding GMED

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SeaCrest Wealth Management's GMED Position: Q3 2022 in Review

SeaCrest Wealth Management sold out of Globus Medical (GMED) in Q3 2022, closing a stake of 549 shares — an estimated $31K sold.

SeaCrest Wealth Management first reported a position in GMED in Q4 2017 and held it in 7 quarters. The position peaked at $114K in Q3 2018. 370 funds tracked by Wall St. Rank hold GMED as of Q3 2022.

SeaCrest Wealth Management reported no remaining Globus Medical position as of Q3 2022 after selling out during the quarter.
SeaCrest Wealth Management sold 549 Globus Medical shares in Q3 2022, an estimated $31K.
SeaCrest Wealth Management first reported a position in Globus Medical in Q4 2017 and held it in 7 quarters.
SeaCrest Wealth Management's Globus Medical position peaked at $114K in Q3 2018.
370 funds tracked by Wall St. Rank held Globus Medical as of Q3 2022.

Based on SeaCrest Wealth Management's 13F filing for Q3 2022, filed 15 Nov 2022.